Stem cells can be used to “encourage” better function in heart failure (HF) patients in the U.K., according to a recent stem cell therapy trial spearheaded by researchers from the University of Edinburgh. Harvested from bone marrow, the stem cells, which were able to generate new cardiac tissue and blood vessels, had a success rate of 80 percent.

Cardiovascular disease (CVD) caused more than a quarter of all deaths in India in 2015, according to a new study in The Lancet Global Health, with rural residents and young adults accounting for most of the recent uptick.

Contrary to popular belief, full-fat dairy products are not directly associated with increasing cardiovascular disease (CVD) and stroke mortality, according to a new study published in the American Journal of Clinical Nutrition.

Despite guidelines and quality improvement efforts, many people with heart failure with reduced ejection fraction (HFrEF) aren’t prescribed the recommended medications. And among those who are, fewer than one-fourth receive optimal doses, according to a registry analysis of ambulatory patients.

Asthma and uncontrolled asthma are associated with a 38 percent increased risk of developing atrial fibrillation (AFib), according to new research published in JAMA Cardiology.

A Cleveland-based startup called XaTek has developed a handheld device that can inform users or physicians about their blood’s clotting ability within 30 minutes.

Low doses (75-100 mg per day) of aspirin were found to be ineffective for people above 154 pounds, while higher doses only reduced cardiovascular events among patients with greater body size.

A retrospective study published July 13 in JAMA Network Open suggests placement of an inferior vena cava (IVC) filter is associated with an increased risk of 30-day mortality for patients with venous thromboembolic disease and a contraindication to anticoagulants.